Published in Nat Med on June 01, 2001
Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A (2002) 30.32
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34
Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A (2001) 19.30
Gene selection and classification of microarray data using random forest. BMC Bioinformatics (2006) 12.45
Coexpression analysis of human genes across many microarray data sets. Genome Res (2004) 9.38
Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol (2004) 7.68
BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol (2002) 6.35
Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci U S A (2006) 6.26
Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics (2006) 4.57
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol (2004) 3.84
Classifying gene expression profiles from pairwise mRNA comparisons. Stat Appl Genet Mol Biol (2004) 3.45
The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat Rev Cancer (2008) 3.43
Simple decision rules for classifying human cancers from gene expression profiles. Bioinformatics (2005) 3.24
Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci U S A (2002) 3.05
Comparing functional annotation analyses with Catmap. BMC Bioinformatics (2004) 2.92
Supervised clustering of genes. Genome Biol (2002) 2.86
Use of hybridization kinetics for differentiating specific from non-specific binding to oligonucleotide microarrays. Nucleic Acids Res (2002) 2.77
Ultrahigh dimensional feature selection: beyond the linear model. J Mach Learn Res (2009) 2.72
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res (2009) 2.59
New feature subset selection procedures for classification of expression profiles. Genome Biol (2002) 2.54
Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res (2008) 2.18
Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. Am J Pathol (2009) 2.14
Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol (2004) 2.14
Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br J Cancer (2003) 2.08
Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum Genet (2003) 2.01
Clustering cancer gene expression data: a comparative study. BMC Bioinformatics (2008) 2.00
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res (2004) 1.96
Feature selection and molecular classification of cancer using genetic programming. Neoplasia (2007) 1.94
The molecular pathology of cancer. Nat Rev Clin Oncol (2010) 1.86
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest (2009) 1.83
Using gene expression to investigate the genetic basis of complex disorders. Hum Mol Genet (2008) 1.82
Large scale comparison of global gene expression patterns in human and mouse. Genome Biol (2010) 1.77
Expression profiling to predict outcome in breast cancer: the influence of sample selection. Breast Cancer Res (2002) 1.72
CMA: a comprehensive Bioconductor package for supervised classification with high dimensional data. BMC Bioinformatics (2008) 1.68
An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol (2005) 1.67
Spurious spatial periodicity of co-expression in microarray data due to printing design. Nucleic Acids Res (2003) 1.61
Classification of ductal carcinoma in situ by gene expression profiling. Breast Cancer Res (2006) 1.59
A comparison of univariate and multivariate gene selection techniques for classification of cancer datasets. BMC Bioinformatics (2006) 1.57
Analysis of time-series gene expression data: methods, challenges, and opportunities. Annu Rev Biomed Eng (2007) 1.55
Systematic learning of gene functional classes from DNA array expression data by using multilayer perceptrons. Genome Res (2002) 1.55
Molecular classification of renal tumors by gene expression profiling. J Mol Diagn (2005) 1.52
Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems. BMC Bioinformatics (2011) 1.50
Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Am J Pathol (2003) 1.49
Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study. BMC Bioinformatics (2002) 1.48
Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol (2002) 1.46
Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement. J Natl Cancer Inst (2011) 1.45
Expression profiling of human tumors: the end of surgical pathology? J Mol Diagn (2001) 1.43
MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis (2011) 1.43
Breast cancer prognosis by combinatorial analysis of gene expression data. Breast Cancer Res (2006) 1.43
Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma. Clin Cancer Res (2010) 1.36
Cluster stability scores for microarray data in cancer studies. BMC Bioinformatics (2003) 1.36
A stable gene selection in microarray data analysis. BMC Bioinformatics (2006) 1.35
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. BMC Genomics (2004) 1.33
An entropy-based gene selection method for cancer classification using microarray data. BMC Bioinformatics (2005) 1.32
Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls. Genomics Proteomics Bioinformatics (2006) 1.30
Random generalized linear model: a highly accurate and interpretable ensemble predictor. BMC Bioinformatics (2013) 1.29
Bayesian rule learning for biomedical data mining. Bioinformatics (2010) 1.29
Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol (2002) 1.29
Application of an efficient Bayesian discretization method to biomedical data. BMC Bioinformatics (2011) 1.27
Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB. Am J Pathol (2005) 1.26
Computational medicine: translating models to clinical care. Sci Transl Med (2012) 1.25
Classification and selection of biomarkers in genomic data using LASSO. J Biomed Biotechnol (2005) 1.23
ISOLATE: a computational strategy for identifying the primary origin of cancers using high-throughput sequencing. Bioinformatics (2009) 1.22
Variability of gene expression profiles in human blood and lymphoblastoid cell lines. BMC Genomics (2010) 1.22
Efficiency analysis of competing tests for finding differentially expressed genes in lung adenocarcinoma. Cancer Inform (2008) 1.21
Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. Br J Cancer (2008) 1.21
High-sensitivity transcriptome data structure and implications for analysis and biologic interpretation. Genomics Proteomics Bioinformatics (2006) 1.21
A combinational feature selection and ensemble neural network method for classification of gene expression data. BMC Bioinformatics (2004) 1.20
Children's Oncology Group's 2013 blueprint for research: bone tumors. Pediatr Blood Cancer (2012) 1.20
Multi-class cancer classification by total principal component regression (TPCR) using microarray gene expression data. Nucleic Acids Res (2005) 1.19
Relative expression analysis for molecular cancer diagnosis and prognosis. Technol Cancer Res Treat (2010) 1.19
Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers. Virchows Arch (2009) 1.19
Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. Br J Cancer (2006) 1.18
Validation of computational methods in genomics. Curr Genomics (2007) 1.18
Optimization based tumor classification from microarray gene expression data. PLoS One (2011) 1.17
Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect. BMC Bioinformatics (2003) 1.17
A short treatise concerning a musical approach for the interpretation of gene expression data. Sci Rep (2015) 1.16
An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. World J Gastroenterol (2004) 1.16
Multiclass cancer classification by using fuzzy support vector machine and binary decision tree with gene selection. J Biomed Biotechnol (2005) 1.16
Discovering biomarkers from gene expression data for predicting cancer subgroups using neural networks and relational fuzzy clustering. BMC Bioinformatics (2007) 1.16
PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett (2008) 1.14
A novel weighted support vector machine based on particle swarm optimization for gene selection and tumor classification. Comput Math Methods Med (2012) 1.13
Suitable reference genes for real-time PCR in human HBV-related hepatocellular carcinoma with different clinical prognoses. BMC Cancer (2009) 1.13
Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. BMC Bioinformatics (2003) 1.13
Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers. PLoS One (2011) 1.13
A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments. BMC Bioinformatics (2008) 1.11
Outcome prediction based on microarray analysis: a critical perspective on methods. BMC Bioinformatics (2009) 1.11
Protein tyrosine phosphatases as potential therapeutic targets. Acta Pharmacol Sin (2014) 1.10
Development and Validation of Biomarker Classifiers for Treatment Selection. J Stat Plan Inference (2008) 1.10
Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction. J Mol Diagn (2007) 1.10
A microarray-based gastric carcinoma prewarning system. World J Gastroenterol (2005) 1.08
microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies. Clin Cancer Res (2009) 1.08
EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo. Cancer Res (2010) 1.08
Gene selection for classification of microarray data based on the Bayes error. BMC Bioinformatics (2007) 1.07
Identification of common differentially expressed genes in urinary bladder cancer. PLoS One (2011) 1.06
Microbial mediation of biogeochemical cycles revealed by simulation of global changes with soil transplant and cropping. ISME J (2014) 1.06
VizStruct: exploratory visualization for gene expression profiling. Bioinformatics (2004) 1.06
Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review. Virchows Arch (2006) 1.05
Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas. Mol Cancer Ther (2009) 1.05
Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy. Hum Genomics (2004) 1.05
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Molecular portraits of human breast tumours. Nature (2000) 94.14
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Gene-expression profiles in hereditary breast cancer. N Engl J Med (2001) 29.80
Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci U S A (2000) 19.39
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53
Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics (2000) 13.33
Ratio-based decisions and the quantitative analysis of cDNA microarray images. J Biomed Opt (1997) 8.32
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res (1998) 4.68
Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene (1990) 3.74
Sequence of an expressed human beta-tubulin gene containing ten Alu family members. Nucleic Acids Res (1984) 3.08
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci U S A (1999) 2.77
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ (1990) 2.24
Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem (1997) 1.96
H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J Cell Biol (1992) 1.89
Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors. Hum Pathol (1983) 1.85
Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am J Pathol (1987) 1.68
Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues. Mod Pathol (2000) 1.68
Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer (1993) 1.63
Acute myocardial infarction detected in the 12-lead ECG by artificial neural networks. Circulation (1997) 1.50
The molecular pathology of small round-cell tumours--relevance to diagnosis, prognosis, and classification. J Pathol (1996) 1.45
Microglia and astrocytes in the adult rat brain: comparative immunocytochemical analysis demonstrates the efficacy of lipocortin 1 immunoreactivity. Neuroscience (2000) 1.45
Diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour based on the detection of t(11;22) using fluorescence in situ hybridisation. Br J Cancer (1993) 1.42
Differentially expressed olfactomedin-related glycoproteins (Pancortins) in the brain. Brain Res Mol Brain Res (1998) 1.42
Neural network analysis of breast cancer from MRI findings. Radiat Med (1998) 1.42
Expression of the Fgf6 gene is restricted to developing skeletal muscle in the mouse embryo. Development (1993) 1.41
Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. Endocrinology (1994) 1.41
Fibroblast growth factor receptors display both common and distinct signaling pathways. Oncogene (1995) 1.39
Human fetal muscle and cultured myotubes derived from it contain a fetal-specific myosin light chain. Science (1983) 1.37
A basis for differentiating among the multiple human Mu-glutathione S-transferases and molecular cloning of brain GSTM5. J Biol Chem (1993) 1.37
Characterization of human glycogenin-2, a self-glucosylating initiator of liver glycogen metabolism. J Biol Chem (1998) 1.21
Artificial neural networks in chest radiography: application to the differential diagnosis of interstitial lung disease. Acad Radiol (1999) 1.20
Two additional protein-tyrosine kinases expressed in human lung: fourth member of the fibroblast growth factor receptor family and an intracellular protein-tyrosine kinase. Proc Natl Acad Sci U S A (1991) 1.20
Myogenesis in cultures of uniparental mouse embryonic stem cells: differing patterns of expression of myogenic regulatory factors. Int J Dev Biol (1997) 1.17
Classification of arrhythmic events in ambulatory electrocardiogram, using artificial neural networks. Comput Biomed Res (1995) 1.16
Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (1992) 17.40
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol (1993) 10.87
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (1984) 9.64
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res (2001) 8.34
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature (1983) 8.18
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (1997) 8.05
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 7.66
Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci U S A (1983) 7.01
Choice behavior and the accessibility of the reinforcer. J Exp Anal Behav (1972) 6.14
Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet (1997) 5.58
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med (1994) 5.28
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J (2001) 4.85
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res (1998) 4.68
Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex. Science (1998) 4.57
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut (2004) 4.39
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol (1988) 4.35
Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature (1985) 4.31
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med (1998) 4.18
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene (2009) 4.10
DPC4 gene in various tumor types. Cancer Res (1996) 3.74
A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. Nature (1983) 3.56
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol (1998) 3.10
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics (2001) 3.05
Nucleotide sequence of the human N-myc gene. Proc Natl Acad Sci U S A (1986) 2.99
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol (1989) 2.89
Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C. Nature (1992) 2.88
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res (2001) 2.80
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci U S A (1999) 2.77
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol (2001) 2.68
Respiratory and irritant health effects of ambient volatile organic compounds. The Kanawha County Health Study. Am J Epidemiol (1993) 2.68
Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther (2001) 2.62
Prohead and DNA-gp3-dependent ATPase activity of the DNA packaging protein gp16 of bacteriophage phi 29. J Mol Biol (1987) 2.59
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res (2001) 2.48
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals. Clin Pharmacol Ther (2007) 2.48
Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res (1997) 2.45
Telomere length in different tissues of elderly patients. Mech Ageing Dev (2000) 2.45
Oncogene amplification in tumor cells. Adv Cancer Res (1986) 2.44
Preventive care: do we practice what we preach? Am J Public Health (1987) 2.44
Metabolic activity and clinical features of primary ganglioneuromas. Cancer (2001) 2.41
Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet (2001) 2.39
Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A (2001) 2.36
Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene (1997) 2.35
Hemorrhage after pancreatoduodenectomy. Ann Surg (1998) 2.35
Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol (1998) 2.34
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys (2000) 2.33
Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature (1984) 2.32
Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity (2001) 2.24
Causal explanations as a risk factor for depression: theory and evidence. Psychol Rev (1984) 2.24
Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol (2000) 2.22
Neoplastic transformation by the human gene N-myc. Mol Cell Biol (1987) 2.17
Human proto-oncogene N-myc encodes nuclear proteins that bind DNA. Mol Cell Biol (1986) 2.15
Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet (1994) 2.09
Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. Pharmacogenetics (2001) 2.08
Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A (1993) 2.08
Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol (2000) 2.05
Interrater reliability of roentgenological evaluation of the lumbar spine in lateral bending. J Manipulative Physiol Ther (1990) 2.04
Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet (2001) 2.02
Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res (2001) 1.99
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin Pharmacol Ther (2013) 1.99
Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci U S A (1984) 1.99
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma. Clin Pharmacol Ther (2011) 1.98
Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther (2013) 1.94
A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem (1999) 1.92
Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol (2000) 1.91
Gene amplification in gastric and esophageal adenocarcinomas. Cancer Res (1990) 1.90
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene (2009) 1.90
Genes necessary for expression of a virulence determinant and for transmission of Plasmodium falciparum are located on a 0.3-megabase region of chromosome 9. Proc Natl Acad Sci U S A (1993) 1.88
Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer (2001) 1.86
MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification. Eur J Cancer (2004) 1.85
Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene. Mol Cell Biol (1985) 1.84
Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Cancer (2000) 1.78
Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet (1996) 1.76
Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature (1984) 1.75
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma. Eur Respir J (2011) 1.74
Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models. Anaesthesia (2007) 1.73
Expression of N-myc in teratocarcinoma stem cells and mouse embryos. Nature (1985) 1.72
Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol (2001) 1.72
Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol (2001) 1.72
Genomic profiling of malignant melanoma using tiling-resolution arrayCGH. Oncogene (2007) 1.72
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int J Cancer (2001) 1.71
UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo. Clin Pharmacol Ther (2009) 1.67
Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci U S A (1995) 1.66
Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile. Cancer Res (2001) 1.66
Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine. Gut (2003) 1.66
Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol (2000) 1.64